指南与共识免疫规划卫生政策与健康促进

使用改良的暴露前预防接种方案预防人狂犬病:美国免疫实践咨询委员会建议——美国,2022年

Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
指南 / 共识 · MMWR Morb Mortal Wkly Rep · 2022-05-06

美国免疫实践咨询委员会(ACIP)基于2019年9月至2021年11月的工作组评估,在六次会议上讨论了2008年建议的更新,并提出了暴露前预防(PrEP)的修改建议,包括重新定义风险类别、减少基础接种剂量、灵活确保长期免疫、减少或不进行抗体滴度检查、新最低抗体滴度0.5国际单位/毫升以及特殊人群接种指导。

要点

  • 重新定义了狂犬病暴露风险类别。
  • 基础暴露前预防接种方案中疫苗剂量减少。
  • 新最低狂犬病抗体滴度为0.5国际单位/毫升。

核心结论

  • 本次报告总结了ACIP对暴露前预防的修改建议,包括重新定义风险类别、减少基础接种剂量、灵活确保长期保护、减少或不进行抗体滴度检查、新最低抗体滴度0.5国际单位/毫升以及特殊人群接种的临床指导。

研究设计与样本

  • ACIP狂犬病工作组于2019年9月至2021年11月评估新发表数据、审查常见问题并识别先前建议的依从障碍,在六次ACIP会议上讨论后提出对2008年ACIP建议的更新。

主要发现

  • ACIP狂犬病工作组在2019年9月至2021年11月期间评估了新发表的数据,审查了常见问题,并识别了遵守先前ACIP狂犬病疫苗接种建议的障碍,相关主题在六次ACIP会议上进行了介绍和讨论。

关键数值与推荐

  • 本次报告总结了以下暴露前预防修改:1)重新定义风险类别;2)基础接种方案中疫苗剂量减少;3)确保长期保护或免疫原性的灵活选择;4)对某些风险群体减少或不进行抗体滴度检查;5)新最低狂犬病抗体滴度为0.5国际单位/毫升;6)临床指导,包括确保某些特殊人群的有效接种。

临床怎么用

  • 暴露前预防不能消除暴露后预防的需要,但可简化狂犬病暴露后预防方案(即消除对狂犬病免疫球蛋白的需求并减少暴露后预防所需的疫苗剂量)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human rabies is an acute, progressive encephalomyelitis that is nearly always fatal once symptoms begin. Several measures have been implemented to prevent human rabies in the United States, including vaccination of targeted domesticated and wild animals, avoidance of behaviors that might precipitate an exposure (e.g., provoking high-risk animals), awareness of the types of animal contact that require postexposure prophylaxis (PEP), and use of proper personal protective equipment when handling animals or laboratory specimens. PEP is widely available in the United States and highly effective if administered after an exposure occurs. A small subset of persons has a higher level of risk for being exposed to rabies virus than does the general U.S. population; these persons are recommended to receive preexposure prophylaxis (PrEP), a series of human rabies vaccine doses administered before an exposure occurs, in addition to PEP after an exposure. PrEP does not eliminate the need for PEP; however, it does simplify the rabies PEP schedule (i.e., eliminates the need for rabies immunoglobulin and decreases the number of vaccine doses required for PEP). As rabies epidemiology has evolved and vaccine safety and efficacy have improved, Advisory Committee on Immunization Practices (ACIP) recommendations to prevent human rabies have changed. During September 2019-November 2021, the ACIP Rabies Work Group considered updates to the 2008 ACIP recommendations by evaluating newly published data, reviewing frequently asked questions, and identifying barriers to adherence to previous ACIP rabies vaccination recommendations. Topics were presented and discussed during six ACIP meetings. The following modifications to PrEP are summarized in this report: 1) redefined risk categories; 2) fewer vaccine doses in the primary vaccination schedule; 3) flexible options for ensuring long-term protection, or immunogenicity; 4) less frequent or no antibody titer checks for some risk groups; 5) a new minimum rabies antibody titer (0.5 international units [IUs]) per mL); and 6) clinical guidance, including for ensuring effective vaccination of certain special populations.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Rao AK, Briggs D, Moore SM, et al. Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35511716. doi:10.15585/mmwr.mm7118a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。